Vera Therapeutics, Inc.
VERA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,339,779 | $656,834 | $514,143 | $568,538 |
| - Cash | $92,646 | $45,681 | $114,653 | $79,674 |
| + Debt | $54,638 | $53,708 | $31,286 | $4,923 |
| Enterprise Value | $2,301,771 | $664,861 | $430,776 | $493,787 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $846 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$144,416 | -$92,182 | -$88,909 | -$32,412 |
| % Margin | – | – | – | – |
| Net Income | -$152,148 | -$95,990 | -$89,056 | -$32,609 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.75 | -2.25 | -3.35 | -2.43 |
| % Growth | -22.2% | 32.8% | -37.9% | – |
| Operating Cash Flow | -$134,679 | -$92,181 | -$67,596 | -$23,708 |
| Capital Expenditures | -$972 | -$63 | -$62 | $0 |
| Free Cash Flow | -$135,651 | -$92,244 | -$67,658 | -$23,708 |